In the NETT Genetics Ancillary Study, we were able to identify variants in two genes, GSTP1 and EPHX1, which may predict outcome from LVRS, even when accounting for clinically-defined subgroups based on radiographic emphysema distribution and baseline exercise capacity. This evidence concerns the gene GSTP1 and pulmonary emphysema.